Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00231491
Status:
COMPLETED
Last Update Posted:
2011-02-17
First Post:
2005-10-03
Brief Title:
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder OAB A Multicenter Phase II Randomized Double-blind Placebo Controlled 6 Month Study VESITOX
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Overactive bladder induce urgency urge incontinence nocturia and pollakiuria This condition is often resistant to anticholinergic drugs used as a first line treatment for this purpose Moreover muscarinic side effects constipation mouth dryness often limits the use of those treatments This study is designed to evaluate the efficacy and safety of botulinum toxin A injected into the detrusor muscle to control symptoms and improve quality of life for patients resistant or intolerant to anticholinergic drugs
Detailed Description:
This study is designed to evaluate the efficacy and safety of botulinum toxin A injected into the detrusor muscle to control symptoms and improve quality of life for patients resistant or intolerant to anticholinergic drugs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None